Erasca
ERAS
13.61
-0.61
-4.29%
Erasca
US · ERAS
#2103 by market cap
Listed 2021
13.61
-0.61
-4.29%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Erasca
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.
- Founded
- 2018
- CEO
- Dr. Jonathan E. Lim,M.D.
- Employees
- 103
- Headquarters
- San Diego, California, United States of America
- Fiscal year end
- 12-31
- Website
- erasca.com
Company profile
- Exchange
- US
- Symbol
- ERAS
- Market-cap rank
- #2103
- Listing date
- 2021-07-16
- Market cap
- 4.78B
- Float cap
- 3.34B
- Shares out
- 350.96M
- Float shares
- 245.21M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
Erasca discussion 0 comments